COVID-19 Antibody Rapid Detection Kit
In response to the coronavirus pandemic, Attikouris Medical is supplying a testing kits to aid in the detection of SARS-CoV-2 (COVID-19) in Cyprus.
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals.
Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals and birds that cause respiratory, enteric, hepatic and neurologic diseases.
Detection Window (IgM): 3-5 days after incubation
Dual band results for simple interpretation
Multivariable analysis of immunoglobin IgG & IgM
Sensitivity: IgG 97.2%; IgM 87.9%
Specificity: IgG 100%; IgM 100%
Specimen: Whole Blood, Serum, Plasma
Time to Results: up to 10 minutes
Shelf Life: 24 months from the date of manufacture
What is the significance of the various test results?
IgM negative, IgG negative: Patient not exposed or too early. A medical professional should observe symptoms and epidemiology of patients. Retesting should be considered if symptoms appear or persist.
IgM positive, IgG positive/negative: Acute or recent infection.
IgM negative, IgG positive: Previous, distant infection.